HESTER BIOSCIENCES Financial Statement Analysis
|
||
|
The Revenues of HESTER BIOSCIENCES have increased by 2.15% YoY .
The Earnings Per Share (EPS) of HESTER BIOSCIENCES has increased by 102.41 % YoY. |
||
HESTER BIOSCIENCES Last 5 Annual Financial Results
[BOM: 524669|NSE : HESTERBIO]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹311 Cr | ₹305 Cr | ₹266 Cr | ₹235 Cr | ₹214 Cr |
| Expenses | ₹250 Cr | ₹251 Cr | ₹216 Cr | ₹175 Cr | ₹146 Cr |
| Operating Profit (Excl OI) | ₹61 Cr | ₹53 Cr | ₹50 Cr | ₹60 Cr | ₹69 Cr |
| Other Income | ₹3.92 Cr | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹4.68 Cr |
| Interest | ₹13 Cr | ₹20 Cr | ₹9.32 Cr | ₹4.06 Cr | ₹6.60 Cr |
| Depreciation | ₹17 Cr | ₹17 Cr | ₹21 Cr | ₹17 Cr | ₹13 Cr |
| Profit Before Tax | ₹40 Cr | ₹32 Cr | ₹40 Cr | ₹54 Cr | ₹50 Cr |
| Profit After Tax | ₹29 Cr | ₹21 Cr | ₹28 Cr | ₹39 Cr | ₹35 Cr |
| Consolidated Net Profit | ₹27 Cr | ₹19 Cr | ₹27 Cr | ₹39 Cr | ₹34 Cr |
| Earnings Per Share (Rs) | ₹65.40 | ₹32.31 | ₹22.20 | ₹31.30 | ₹46.22 |
| PAT Margin (%) | 17.27 | 9.26 | 6.94 | 10.46 | 16.67 |
| ROE(%) | 17.05 | 9.51 | 7.41 | 10.39 | 16.17 |
| ROCE(%) | 16.21 | 9.93 | 9.59 | 9.60 | 14.12 |
| Total Debt/Equity(x) | 0.52 | 0.66 | 0.82 | 0.96 | 0.86 |
Key Financials |
||
| Market Cap | : | ₹ 1,877.5 Cr |
| Revenue (TTM) | : | ₹ 332.6 Cr |
| Net Profit(TTM) | : | ₹ 51.1 Cr |
| EPS (TTM) | : | ₹ 60.1 |
| P/E (TTM) | : | 36.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HESTER BIOSCIENCES | -0% | 13% | 19.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | 6.4% | 12.1% |
| DIVIS LABORATORIES | 3% | 2.8% | 0.9% |
| TORRENT PHARMACEUTICALS | 2.3% | 9.1% | 44.6% |
| CIPLA | 0.3% | 6.1% | -3.7% |
| DR REDDYS LABORATORIES | -0.1% | 8.9% | 1.9% |
| MANKIND PHARMA | 1.8% | 6.7% | 8% |
| LUPIN | 2.9% | 9.5% | 24.5% |
| ZYDUS LIFESCIENCES | 1.7% | 6% | 12% |
HESTER BIOSCIENCES Revenues
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | 2.15 % |
| 5 Yr CAGR | 9.76 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹311 Cr | 2.15 | |
| Mar2025 | ₹305 Cr | 14.45 | |
| Mar2024 | ₹266 Cr | 13.23 | |
| Mar2023 | ₹235 Cr | 9.65 | |
| Mar2022 | ₹214 Cr | - | |
HESTER BIOSCIENCES Operating Profit
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | 14.83 % |
| 5 Yr CAGR | -2.89 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹61 Cr | 14.83 | |
| Mar2025 | ₹53 Cr | 5.48 | |
| Mar2024 | ₹50 Cr | -15.97 | |
| Mar2023 | ₹60 Cr | -12.64 | |
| Mar2022 | ₹69 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 12.37 % |
| 5 Yr CAGR | -11.53 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 19.62% | 12.37 | |
| Mar2025 | 17.46% | -7.81 | |
| Mar2024 | 18.94% | -25.78 | |
| Mar2023 | 25.52% | -20.32 | |
| Mar2022 | 32.03% | - | |
HESTER BIOSCIENCES Profit After Tax
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | 45.52 % |
| 5 Yr CAGR | -5.47 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | 45.52 | |
| Mar2025 | ₹19 Cr | -29.06 | |
| Mar2024 | ₹27 Cr | -32.28 | |
| Mar2023 | ₹39 Cr | 14.20 | |
| Mar2022 | ₹34 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 86.50 % |
| 5 Yr CAGR | 0.89 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 17.27 % | 86.50 | |
| Mar2025 | 9.26 % | 33.43 | |
| Mar2024 | 6.94 % | -33.65 | |
| Mar2023 | 10.46 % | -37.25 | |
| Mar2022 | 16.67 % | - | |
HESTER BIOSCIENCES Earnings Per Share (EPS)
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | 102.41 % |
| 5 Yr CAGR | 9.07 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹65 | 102.41 | |
| Mar2025 | ₹32 | 45.54 | |
| Mar2024 | ₹22 | -29.07 | |
| Mar2023 | ₹31 | -32.28 | |
| Mar2022 | ₹46 | - | |
HESTER BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 524669|NSE : HESTERBIO]
| Y-o-Y | 63.24 % |
| 5 Yr CAGR | 3.51 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 16.21% | 63.24 | |
| Mar2025 | 9.93% | 3.55 | |
| Mar2024 | 9.59% | -0.10 | |
| Mar2023 | 9.6% | -32.01 | |
| Mar2022 | 14.12% | - | |
HESTER BIOSCIENCES Share Price vs Sensex
| Current Share Price | : | ₹2,208.9 |
| Current MarketCap | : | ₹ 1,877.5 Cr |
| Updated EOD on | : | Jul 03,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -0% |
13% |
19.9% |
| SENSEX | 0.9% |
4.2% |
-6% |
HESTER BIOSCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 3.1% | 8.2% | 14.9% |
You may also like the below Video Courses
FAQ about HESTER BIOSCIENCES Financials
How the annual revenues of HESTER BIOSCIENCES have changed ?
The Revenues of HESTER BIOSCIENCES have increased by 2.15% YoY .
How the Earnings per Share (EPS) of HESTER BIOSCIENCES have changed?
The Earnings Per Share (EPS) of HESTER BIOSCIENCES has increased by 102.41 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs